ZBTB16
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
28415single nucleotide variantNM_006006.4(ZBTB16):c.1849A>G (p.Met617Val)121434606MedGen:C2676231,OMIM:61244711114121104114121104AG
28415single nucleotide variantNM_006006.4(ZBTB16):c.1849A>G (p.Met617Val)121434606MedGen:C2676231,OMIM:61244711114250382114250382AG
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
11113957880rs2606724GArs26067242.00E-04TOPIRAMATE|FRUCTOSEANTICONVULSANTSCognitive impairment induced by topiramateHPOID:0100543DOID:1561CintronGWASdb_drug
11113975446rs238924AGrs2389242.68E-04GEMCITABINE|CYTARABINEMANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINEResponse to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162TintronGWASdb_drug
11114023016rs12293744CTrs122937445.23E-05TOPIRAMATE|FRUCTOSEANTICONVULSANTSCognitive impairment induced by topiramateHPOID:0100543DOID:1561CintronGWASdb_drug
11114023946rs11214881TCrs112148817.66E-06TOPIRAMATE|FRUCTOSEANTICONVULSANTSCognitive impairment induced by topiramateHPOID:0100543DOID:1561TintronGWASdb_drug
11114063362rs589916GTrs5899169.90E-04ALDOSTERONEBIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENINBlood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_drug
11114092582rs573264AGrs5732644.77E-04ALDOSTERONEBIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENINBlood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_drug
11113940469rs3018331CArs30183317.84E-04Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
11113945609rs1672692GArs16726923.52E-05Lung adenocarcinomaHPOID:0100526DOID:3910GintronGWASdb_trait
11113949232rs1784692TCrs17846926.43E-05Lung adenocarcinomaHPOID:0100526DOID:3910AintronGWASdb_trait
11113957880rs2606724GArs26067242.00E-04Cognitive impairment induced by topiramateHPOID:0100543DOID:1561CintronGWASdb_trait
11113961762rs17116334CTrs171163349.00E-06Conduct disorder (interaction)HPOID:0100851DOID:12995CintronGWASdb_trait
11113969669rs10488697AGrs104886972.20E-05Homocysteine levels, in plasmaHPOID:0010919DOID:1936|DOID:3393TintronGWASdb_trait
11113969669rs10488697AGrs104886976.51E-06Blood PressureHPOID:0011025DOID:10763TintronGWASdb_trait
11113975446rs238924AGrs2389242.68E-04Response to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162TintronGWASdb_trait
11113981241rs17116384AGrs171163841.77E-04Sudden cardiac arrestHPOID:0001645DOID:3393AintronGWASdb_trait
11113984489rs238913AGrs2389131.25E-05Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
11113984489rs238913AGrs2389138.05E-05Sudden cardiac arrestHPOID:0001645DOID:3393CintronGWASdb_trait
11113984975rs2073844AGrs20738448.08E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312TintronGWASdb_trait
11113984975rs2073844AGrs20738445.19E-05Potassium levelsHPOID:0001627|HPOID:0000822|HPOID:0011042DOID:10763|DOID:114TintronGWASdb_trait
11113986879rs238910AGrs2389103.66E-05Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
11113990717rs238899TCrs2388997.83E-04Type 2 diabetesHPOID:0005978DOID:9352AintronGWASdb_trait
11113994044rs238898CGrs2388981.52E-04Type 2 diabetesHPOID:0005978DOID:9352GintronGWASdb_trait
11113994044rs238898CGrs2388985.75E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
11113994374rs238897AGrs2388975.29E-04Type 2 diabetesHPOID:0005978DOID:9352TintronGWASdb_trait
11113994505rs238896GArs2388966.48E-04Type 2 diabetesHPOID:0005978DOID:9352TintronGWASdb_trait
11113997675rs2735207CTrs27352071.15E-04Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
11113997994rs238889TCrs2388896.40E-05Type 2 diabetesHPOID:0005978DOID:9352GintronGWASdb_trait
11113998602rs238887CGrs2388878.66E-05Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
11114000727rs926075CTrs9260757.34E-04Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
11114003347rs10488696GArs104886968.46E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312CintronGWASdb_trait
11114004128rs12278218CTrs122782188.70E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312CintronGWASdb_trait
11114007713rs717676GTrs7176762.45E-04Bicuspid aortic valveHPOID:0001724|HPOID:0001647|HPOID:0001682DOID:1682GintronGWASdb_trait
11114023016rs12293744CTrs122937445.23E-05Cognitive impairment induced by topiramateHPOID:0100543DOID:1561CintronGWASdb_trait
11114023016rs12293744CTrs122937440.0004Normoxic and mild-hypoxic adaptation in populations residing at low and moderate altitudesHPOID:0002795DOID:2841|DOID:3083CintronGWASdb_trait
11114023864rs485550CTrs4855509.84E-04Alzheimer's diseaseHPOID:0002511DOID:10652AintronGWASdb_trait
11114023946rs11214881TCrs112148817.66E-06Cognitive impairment induced by topiramateHPOID:0100543DOID:1561TintronGWASdb_trait
11114023946rs11214881TCrs112148810.0004Normoxic and mild-hypoxic adaptation in populations residing at low and moderate altitudesHPOID:0002795DOID:2841|DOID:3083TintronGWASdb_trait
11114028774rs622200TCrs6222002.31E-04SchizophreniaHPOID:0100753DOID:5419AintronGWASdb_trait
11114037061rs1184748AGrs11847482.91E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312CintronGWASdb_trait
11114037158rs513039GArs5130399.02E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312GintronGWASdb_trait
11114038866rs672849CTrs6728498.47E-04Type 2 diabetesHPOID:0005978DOID:9352GintronGWASdb_trait
11114038866rs672849CTrs6728491.49E-05Type 2 diabetesHPOID:0005978DOID:9352GintronGWASdb_trait
11114039225rs686989GArs6869899.09E-04Type 2 diabetesHPOID:0005978DOID:9352TintronGWASdb_trait
11114039225rs686989GArs6869892.68E-06Type 2 diabetesHPOID:0005978DOID:9352TintronGWASdb_trait
11114045560rs500629CArs5006293.62E-05Male-pattern baldnessHPOID:0001596DOID:987TintronGWASdb_trait
11114051904rs2073848TCrs20738482.00E-04SchizophreniaHPOID:0100753DOID:5419AintronGWASdb_trait
11114066438rs3782007GArs37820076.89E-04SchizophreniaHPOID:0100753DOID:5419CintronGWASdb_trait
11114072875rs3782000CTrs37820001.84E-07AutismHPOID:0000717DOID:0060041GintronGWASdb_trait
11114074681rs583647GArs5836474.70E-05Lung function (forced expiratory volume in 1 second)HPOID:0002088DOID:850CintronGWASdb_trait
11114074756rs583200CTrs5832003.09E-04Lung function (forced expiratory volume in 1 second)HPOID:0002088DOID:850AintronGWASdb_trait
11114076935rs12273315GArs122733153.08E-04Tourette syndromeHPOID:0000709DOID:11119|DOID:10933|DOID:1094GintronGWASdb_trait
11114081271rs405388GArs4053884.07E-05Glucose levelsHPOID:0000819DOID:9352CintronGWASdb_trait
11114084859rs549427GArs5494273.88E-04Nicotine smokingHPOID:0000707DOID:0050742CintronGWASdb_trait
11114087467rs397461CTrs3974612.42E-04Response to taxane treatment (placlitaxel)HPOID:0100526DOID:1324GintronGWASdb_trait
11114087577rs424337CGrs4243377.27E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312CintronGWASdb_trait
11114089435rs375620TArs3756202.58E-04Type 2 diabetesHPOID:0005978DOID:9352AintronGWASdb_trait
11114092582rs573264AGrs5732644.77E-04Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_trait
11114093055rs3781990CTrs37819907.80E-06Crohn's diseaseHPOID:0100280DOID:8778GintronGWASdb_trait
11114103913rs382312CTrs3823123.61E-05Coronary heart diseaseHPOID:0001677DOID:3393CintronGWASdb_trait
11114112013rs387301GArs3873012.16E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000109906.13 ZBTB16 176797